Display options
Share it on

Value Health. 2014 Nov;17(7):A457-8. doi: 10.1016/j.jval.2014.08.1258. Epub 2014 Oct 26.

Aripiprazole Once-Monthly is a Cost-Effective Therapeutic Option in the Maintenance Treatment of Schizophrenia: Results from a Markov Model.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

C Sapin, M J Tempest, F Gaughran, M Beillat, P Robinson, M Treur

Affiliations

  1. Lundbeck SAS, Issy les Moulineaux, France.
  2. Pharmerit Ltd, York, UK.
  3. South London and Maudsley NHS Foundation Trust, London, England.
  4. Otsuka Pharmaceutical Europe Ltd, Wexham, UK.
  5. Pharmerit International, Rotterdam, The Netherlands.

PMID: 27201270 DOI: 10.1016/j.jval.2014.08.1258

[No abstract available.]

Publication Types